Molecular Devices CatchPoint cAMP


CatchPoint cAMP

Cell signaling via G protein-coupled receptors (GPCRs) can be assessed by monitoring the downstream effectors calcium or cyclic AMP (cAMP). Monitoring levels of cAMP, a second messenger produced in response to activation of adenylate cyclase, is one of the most common ways to screen for agonists and antagonists of GPCRs.     
The CatchPoint® cyclic-AMP Assay Kit's high-affinity reagents are optimized for sensitivity and precision in applications where cAMP levels are low. A single wash step removes unbound material prior to the development step, so the assay is very resistant to interference from colored or fluorescent test compounds. The proprietary Stoplight RedTM substrate is used to generate a stable fluorescent readout, allowing the assay to be read in as little as 10 minutes or up to 24 hours after substrate addition.

* This item has been discontinued by the manufacturer.


  • High affinity reagents are optimized for sensitivity when cAMP levels are low, ensuring results when other assays fail.     
  • Robust format resists interference from colored or fluorescent compounds, improving reliability of results.     
  • Rapid signal development (< 10 min) and no termination step give users a flexible read time that is compatible with automation and high-throughput screening.     
  • Quantitative method allows accurate determination of cAMP in samples.     


Manuals and Resources

Note: We appreciate the support of individuals and companies making their documents and resources available to our community. If you find a document or resource that does not belong please let us know by emailing

Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life...

More about Molecular Devices

Visit Molecular Devices

Questions and Answers

Recent Question Activity

Be the first to Ask a Question


Member Reviews

There are no threads in Molecular Devices CatchPoint cAMP Reviews at this time.
Add a Review